Table 2.
Dosage form | SC or IM injection |
SC implant | |
Dose volume (injectable): | 2–4 mL |
Size (conventional implant): | ∼4 cm long; outer diameter ∼2 mm |
Alternative implant design: | Consistent with end user acceptability |
Time to sustainable effective exposure: | 24 h |
Other key specifications/attributes: | Minimal drug burst after dosing |
No prolonged PK tail | |
Scalable manufacturing | |
Cost effective relative to existing PrEP products | |
Administration/use consistent with comparable contraceptive products |
IM, intramuscular; PrEP, preexposure prophylaxis; SC, subcutaneous.